Heterogeneous nuclear ribonucleoprotein K pseudogene 2 (HNRNPKP2)

Heterogeneous nuclear ribonucleoprotein K pseudogene 2 (HNRNPKP2) is identified as a pseudogene—a genomic DNA sequence similar to a gene but nonfunctional; it does not encode a functional protein and generally lacks therapeutic or direct biological target status[1]. While parental genes of this family, such as HNRNPK, have established biological roles (e.g., RNA binding, regulation of gene expression, involvement in cell proliferation, cancer, and apoptosis), pseudogenes like HNRNPKP2 are generally nonfunctional in terms of protein coding. However, recent research suggests that pseudogenes as a class can have regulatory roles—such as acting as competitive endogenous RNAs (ceRNAs), participating in gene expression regulation, or modulating the activity of related genes through various RNA-mediated mechanisms[3]. There is no evidence that HNRNPKP2 itself is a therapeutic target or has been directly implicated in any specific disease as a biomarker or target[1][3][5]. Key context: - HNRNPKP2 is distinct from HNRNPK, its functional paralog, which is a protein-coding heterogenous nuclear ribonucleoprotein involved in a range of important cellular processes[2][6]. - Pseudogenes like HNRNPKP2 can sometimes participate in cellular regulation or disease indirectly, but most are transcriptionally inactive or have only minor regulatory functions[3][5]. - There are no known drugs, mechanisms of action, or safety considerations associated specifically with HNRNPKP2[1][3].

Other names

HNRNPKP2